Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains

Clinics

Volumn 66, Issue 4, 2011, Pages 543-547

  Nakano, Viviane ^a   e Silva, Amanda do Nascimento ^a   Merino, Victor Rafael Castillo ^a   Wexler, Hannah M ^b,c   Avila Campos, Mario Julio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

lactamase activity; Antimicrobial resistance; Bacteroides spp.; Parabacteroides distasonis; Resistance genes

Indexed keywords

ANTIINFECTIVE AGENT; IMIPENEM; METRONIDAZOLE;

ANALYSIS OF VARIANCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTEROIDES; CHILD; DRUG EFFECT; GENETICS; HUMAN; INTESTINE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BACTEROIDES; CHILD; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; IMIPENEM; INTESTINES; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 79958727213     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000400004     Document Type: Article

References (31)

1. Sakamoto M, Benno Y. Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as Parabacteroides distasonis gen. nov., comb. nov., Parabacteroides goldsteinii comb. nov. and Parabacteroides merdae com. nov. Int J Syst Evol Microb. 2006;56:1599-1605, doi: 10.1099/ijs.0.64192-0.
2. Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJC, et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother. 2007;51:1649-1655, doi: 10. 1128/AAC.01435-06.
3. Wybo I, Pierard D, Verschraegen I, Reynders M, Vandoorslaer K, Clayes G, et al. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother. 2007;59:132-139. doi: 10.1093/jac/dkl458.
4. Odou MF, Muller C, Calvet L, Dubreuil L. In vitro activity against anaerobes of retapamulin a new topical antibiotic for treatment of skin infections. J Antimicrob Chemother. 2007;59:646-651, doi: 10.1093/jac/dkm019.
5. Gutacker M, Valsangiacomo C, Piffaretti JC. Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes. Microbiology. 2000;146:1241-1244.
6. Papaparaskevas J, Pantazatou A, Katsandri A, Legakis NJ, Avlamis A. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece. Clin Microbio Infect. 2005;11:820-824, doi: 10.1111/j. 1469-0691.2005.01233.x.
7. Podglajen I, Breuil J, Rohaut A, Monsempes C, Collatz E. Multiple mobile promoter regions for the rare carbapenem resistance gene of Bacteroides fragilis. J Bacteriol. 2001;183:3531-3535, doi: 10.1128/JB.183.11. 3531-3535.2001.
8. Ulger NT, Gülliioglu BM, Çakici O, Akin L, Dermirkalem P, Çelenk T, et al. Do antimicrobial susceptibility patterns of colonic isolates of Bacteroides species change after antibiotic prophylaxis with cefoxitin during elective abdominal surgey? World J Surg. 2005;29:1311-1315, doi: 10. 1007/s00268-005-7961-3.
9. Gupta A, Vlamakis H, Shoemaker N, Salyers AA. A new Bacteroides conjugative transposon that carries an ermB gene. Appl Environ Microbiol. 2003;69:6455-6463, doi: 10.1128/AEM.69.11.6455-6463.2003.
10. Haggoud A, Reysset G, Azeddoug H, Sebald M. Nucleotide sequence analysis of two 5-nitroimidazole resistance determinants from Bacteroides strains and of a new insertion sequence upstream of the two genes. Antimicrob Agents Chemother. 1994;38:1047-1051.
11. Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50:16-23, doi: 10.1086/647939.
12. Jousimies-Somer H, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM. Wadsworth-KTL Anaerobic Bacteriology Manual. 6 th ed. Belmont, CA: Star Publishing; 2002.
13. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. 7 th ed., Approved Standard M11-A7. CLSI, Wayne, PA, US, 2007.
14. Betriu C, Culebras E, Gómez M, López F, Rodríguez-Avial I, Picazo JJ. Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain. Antimicrob Agents Chemother. 2008;52: 2686-2690, doi: 10.1128/AAC.00081-08.
15. Cáceres M, Zhang G, Weintraub A, Nord CE. Prevalence and antimicrobial susceptibility of enterotoxigenic Bacteroides fragilis in children with diarrhea in Nicaragua. Anaerobe. 2000;6:143-148, doi: 10. 1006/anae.2000.0341.
16. Paula GR, Falcão LS, Antunes ENF, Avelar KES, Reis FNA, Maluhy MA, et al. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility. Int J Antimcrob Agents. 2004;24:53-58, doi: 10.1016/j.ijantimicag.2003.11.011.
17. Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003. J Antimicrob Chemother. 2006;57:992-998, doi: 10.1093/jac/dkl052.
18. Sóki J, Urban E, Fodor SE, Nagy E. Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary. J Med Microbiol. 2000;49:427-430.
19. Ang L, Brenwald NP, Walker RM, Andrews J, Fraise A. Carbapenem resistance in Bacteroides fragilis. J Antimicrob Chemother. 2007;59:1042-1044, doi: 10.1093/jac/dkm062.
20. García N, Gutiérrez G, Lorenzo M, García JE, Píriz S, Quesada A. Genetic determinants for cfxA expression in Bacteroides strains isolated from human infections. J Antimicrob Chemother. 2008;62:942-947, doi: 10.1093/jac/dkn347.
21. Walsh TR, Onken A, Haldorsen B, Toleman MA, Sundsfjord A. Characterization of a carbapenemase-producing clinical isolates of Bacteroides fragilis in Scandinavia: genetic analysis of a unique insertion sequence. Scand J Infect Dis. 2005;37:676-679, doi: 10.1080/00365540510034482.
22. Heddberg M, Nord CE. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clin Microbiol Infect. 2003;9:475-488, doi: 10.1046/j.1469-0691.2003.00674.x.
23. Chung WO, Werckenthin C, Schwarz S, Roberts MC. Host range of the ermF rRNA methylase gene in bacteria of human and animal origin. J Antimicrob Chemother. 1999;43:5-14, doi: 10.1093/jac/43.1.5.
24. Shoemaker NB, Vlamakis H, Hayes K, Salyers AA. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol. 2001;67:561-568.
25. Pumbwe L, Wareham DW, Aduse-Opoku J, Brazier JS, Wexler HM. Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. Clin Microbiol Infect. 2007;13:183-189, doi: 10. 1111/j.1469-0691.2006.01620.x.
26. Hedberg W, Shahin M, Rotimi VO. Antimicrobial susceptibilities of Bacteroides fragilis group isolates in Europe. Clin Microbiol Infect, 2003; 9:475-488, doi: 10.1046/j.1469-0691.2003.00674.x.
27. Jamal W, Shahin M, Rotimi VO. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007. Anaerobe. 2010;16:1-5, doi: 10.1016/j.anaerobe.2009.04.004.
28. Nickolich MP, Shoemaker NB, Salyers AA. A Bacteroides tetracycline resistance gene represents a new class of ribosome protection tetracycline resistance. Ant Agents Chemother. 1992;36:1005-1012.
29. Leng Z, Riley DE, Berger RE, Krieger JN, Roberts MC. Distribution and mobility of the tetracycline resistance determinant tetQ. J Antimicrob Chemother. 1997;40:551-559, doi: 10.1093/jac/40.4.551.
30. Manch-Citron JN, Lopez GH, Dey A, Rapley JW, MacNeill SR, Cobb CM. PCR monitoring for tetracycline resistance gene in subgingival plaque following site-specific periodontal therapy. J Clin Periodontol. 2000;27:437-446, doi: 10.1034/j.1600-051x.2000.027006437.x.
31. Thrinh S, Reysset G. Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp. J Clin Microbiol. 1996;34:2078-2084.